ResearcherUniversity of Colorado AnschutzActive in the last 2 years

Hayley J Hawkins

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0950-1621; OpenAlex author ID A5041708462. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2024: 1 paper

Papers 1

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL). Co-author DOI 10.1371/journal.pone.0298808 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

John J. Arcaroli · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Alexis Diane Leal · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Christopher Hanyoung Lieu · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Robert William Lentz · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Todd M. Pitts · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Sarah J. Hartman · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗
Wells A. Messersmith · 1 shared paper, 2024 · strength 0.18
- Paper Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tum… DOI 10.1371/journal.pone.0298808 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.